Jirair Ratevosian
Jirair Ratevosian is an associate research scientist at Yale University and a former head of staff for Pepfar, the U.S. government's global HIV/AIDS initiative. He is known for his work in HIV prevention and treatment, advocating for increased political and financial commitment to innovative solutions in combating the epidemic. Ratevosian has highlighted the implications of U.S. funding cuts on global HIV prevention efforts and the urgent need for sustained resources to continue the progress made in reducing new infections.
Not in the pool (under ¢1).
Recent news mentions
Jirair Ratevosian, a former head of staff at Pepfar, emphasized the importance of activism in changing waiver rules for HIV funding.
Small win for activists, but SA’s HIV projects won’t reopen – The Mail & Guardian
South Africa· 2025-07-23
Jirair Ratevosian is a former Pepfar head of staff and an associate research scientist at Yale University.
The six-monthly anti-HIV jab could end Aids in SA by 2032 – The Mail & GuardianSouth Africa· 2025-04-09
